Oncology and Hematology
Episodes 33-48 of 116
Ghassan K. Abou-Alfa, MD
Aiwu Ruth He, MD, PhD
- MinuteCE®
Pivotal Data Supporting First-Line Atezolizumab/Bevacizumab in Unresectable HCC
1.00 program creditAiwu Ruth He, MD, PhD
- MinuteCE®
Emerging First-Line ICI Combination Regimens in Patients With Unresectable HCC
1.00 program creditGhassan K. Abou-Alfa, MD
- MinuteCE®
Practice Changing Highlights in G/GEJ Cancers: The Latest Data from Chicago
1.25 program creditsSamuel J. Klempner, MD
Jolan Walter, MD, PHD
Teresa K. Tarrant, MD
Peter E. Newburger, MD
Jacob R. Bledsoe, MD
Teresa K. Tarrant, MD
Teresa K. Tarrant, MD
Jolan Walter, MD, PHD
Peter E. Newburger, MD
Peter E. Newburger, MD
Peter E. Newburger, MD
Yelena Janjigian, MD
Samuel J. Klempner, MD
Yelena Janjigian, MD
Samuel J. Klempner, MD
Yelena Janjigian, MD
Samuel J. Klempner, MD